Reviva pharmaceuticals to present at the 2024 bio ceo & investor conference

Cupertino, calif., feb. 20, 2024 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the 2024 bio ceo & investor conference, taking place february 26-27, 2024, in new york, ny.
RVPH Ratings Summary
RVPH Quant Ranking